Towards an Effective Virtual R&D Team for Faster Accessing of the East Asian Market

Track:
Innovative Partnering Models and Outsourcing Strategies

Day & Time:
June 26, 1:45PM - 3:15PM

Session Number:
344

Room Number:
102AB

Level:
Intermediate

Type:
Session

Title:
Towards an Effective Virtual R&D Team for Faster Accessing of the East Asian Market

Chair(s):
Deborah Chee, MD,PhD,MBA
Medical Director
AbbVie Korea Ltd., Korea, Republic of

Description:
Strategic use of a “virtual” R&D team model could benefit companies that have limited capabilities in East Asian markets - including Japan, China, Korea and Taiwan - to minimize the drug lag and to maximize product value in these markets.

Learning Objective(s):
Describe the benefits of the virtual R&D team model for companies with limited R&D capabilities in certain target markets; Recognize the virtual R&D team model as a promising option for accessing the East Asian market.

Presentation(s) & Speaker(s):
Program Management: Striving for Productive Conversations, Team Chemistry and a Drive for Results
Philip Bonasia, PhD
Executive Director and Head, Chemistry and Pharmaceutical Sciences
Sunovion Pharmaceuticals Inc., United States

Drug Lag, Regulatory Innovation and the Role of the Academic Center in East Asia
Howard Lee, MD,PhD
Professor, Department of Clinical Pharmacology and Therapeutics
Seoul National University Hospital, Korea, Republic of

Challenges and Successes of Virtual R&D Teams for East Asia
Chris Bruenger, MD
President and CEO
IDEC Inc., Japan